Drugs / Ad100-gp96Ig-HLA A1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00503568 | May 2007 → Aug 2012 | lung cancer | University of Miami | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad100-gp96Ig-HLA A1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00503568 ↗ |
| Modality | Vaccine | “an immunogenic human tumor cell vaccine” NCT00503568 ↗ |